All Stories

  1. CAR-engineered cell therapies: current understandings and future perspectives
  2. Analyzing the expression pattern of the noncoding RNAs (HOTAIR, PVT‐1, XIST, H19, and miRNA‐34a) in PBMC samples of patients with COVID‐19, according to the disease severity in Iran during 2022–2023: A cross‐sectional study
  3. A debate on elimination of dog-mediated human rabies in developing countries by 2030
  4. Oncoviruses: Induction of cancer development and metastasis by increasing anoikis resistance
  5. Interleukin-2 and Oncolytic Virotherapy: A New Perspective in Cancer Therapy
  6. Bile effects on the Pseudomonas aeruginosa pathogenesis in cystic fibrosis patients with gastroesophageal reflux
  7. Collateral sensitivity: An evolutionary trade‐off between antibiotic resistance mechanisms, attractive for dealing with drug‐resistance crisis
  8. Evaluation of MicroRNAs expression pattern (miR-28, miR-181a, miR-34a, and miR-31) in Patients with COVID-19 Admitted to ICU, and Diabetic COVID-19 patients
  9. Neuroprotective effects of glycosides
  10. Evaluation of the Expression Pattern of 4 microRNAs and their Correlation with Cellular/viral Factors in PBMCs of Long Term Non-progressors and HIV Infected Naïve Individuals
  11. Cell death pathways and viruses: Role of microRNAs
  12. Human papillomavirus and prostate cancer: The role of viral expressed proteins in the inhibition of anoikis and induction of metastasis
  13. The role of HPV gene expression and selected cellular MiRNAs in lung cancer development
  14. Exosomes and Lung Cancer: Roles in Pathophysiology, Diagnosis and Therapeutic Applications
  15. The assessment of a possible link between HPV‐mediated inflammation, apoptosis, and angiogenesis in Prostate cancer
  16. The assessment of selected MiRNAs profile in HIV, HBV, HCV, HIV/HCV, HIV/HBV Co-infection and elite controllers for determination of biomarker
  17. The association between HPV gene expression, inflammatory agents and cellular genes involved in EMT in lung cancer tissue
  18. The role of Epstein‐Barr virus‐expressed genes in breast cancer development
  19. Exosomal microRNAs: novel players in cervical cancer
  20. Circular RNAs: New Epigenetic Signatures in Viral Infections
  21. MicroRNAs and exosomes: key players in HIV pathogenesis
  22. Viral infections and risk of thyroid cancer: A systematic review and empirical bayesian meta-analysis
  23. Exosomal miRNAs: novel players in viral infection
  24. Evaluation of CCR5‐Δ32 mutation among individuals with high risk behaviors, neonates born to HIV‐1 infected mothers, HIV‐1 infected individuals, and healthy people in an Iranian population
  25. The role of miR‐146a in viral infection
  26. Pathogenic role of exosomes and microRNAs in HPV‐mediated inflammation and cervical cancer: A review
  27. microRNAs: New prognostic, diagnostic, and therapeutic biomarkers in cervical cancer
  28. Association between human papillomavirus infection and prostate cancer: A global systematic review and meta‐analysis
  29. microRNAs: Key players in virus‐associated hepatocellular carcinoma
  30. Genetic and epigenetic contribution to astrocytic gliomas pathogenesis
  31. Influenza vaccine: Where are we and where do we go?
  32. Epstein-Barr virus and thyroid cancer: The role of viral expressed proteins
  33. miRNA-based strategy for modulation of influenza A virus infection
  34. Gene-knocked out chimeric antigen receptor (CAR) T cells: Tuning up for the next generation cancer immunotherapy
  35. Breast cancer diagnosis: Imaging techniques and biochemical markers
  36. MicroRNAs and exosomes in depression: Potential diagnostic biomarkers
  37. MicroRNAs in retinoblastoma: Potential diagnostic and therapeutic biomarkers
  38. MicroRNA: A novel target of curcumin in cancer therapy
  39. Therapeutic application of multipotent stem cells
  40. Epi-Drugs and Epi-miRs: Moving Beyond Current Cancer Therapies
  41. Boron neutron capture therapy: Moving toward targeted cancer therapy